MARC Record from marc_columbia

LEADER: 03113mam a2200421 a 4500
001 4066317
005 20221027030514.0
008 010124t20012001maua b 001 0 eng d
010 $a 2001025053
020 $a0865424462
035 $a(OCoLC)45306167
035 $a(OCoLC)ocm45306167
035 $a(CStRLIN)MDNM101085594-B
035 $a(DNLM)101085594
035 $9ATX9932HS
035 $a(NNC)4066317
035 $a4066317
040 $aDNLM$cDNLM$dNNC-M$dOrLoB-B
042 $apcc
060 10 $aWH 322$bK93m 2001
100 1 $aKroll, Michael H.$0http://id.loc.gov/authorities/names/n2001126843
245 10 $aManual of coagulation disorders /$c[by] Michael H. Kroll.
260 $aMalden, MA :$bBlackwell Science,$c[2001], ©2001.
300 $aix, 241 pages :$billustrations ;$c23 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliograhical references and index.
505 00 $gCh. 1.$tMechanisms of Coagulation --$gCh. 2.$tThe Biological Basis for Routine Coagulation Testing --$gCh. 3.$tAn Overview of Thrombotic Disorders and Their Treatment --$gCh. 4.$tVenous Thromboembolism --$gCh. 5.$tAnticoagulant Therapy --$gCh. 6.$tArterial Thrombosis --$gCh. 7.$tAntiplatelet Agents --$gCh. 8.$tThrombolytic Therapy --$gCh. 9.$tLupus Anticoagulants, Antiphospholipid Antibodies, and the Antiphospholipid Syndrome --$gCh. 10.$tHypercoagulable States --$gCh. 11.$tThrombocytosis --$gCh. 12.$tThrombotic Thrombocytotic Purpura and the Hemolytic-Uremic Syndrome --$gCh. 13.$tAn Overview of Hemorrhagic Disorders and Their Treatment --$gCh. 14.$tThrombocytopenia --$gCh. 15.$tQualitative Platelet Disorders --$gCh. 16.$tVon Willebrand Disease --$gCh. 17.$tHemophilia and Other Coagulation Factor Deficiencies --$gCh. 18.$tCoagulation Factor Inhibitors --$gCh. 19.$tAcquired Coagulopathies.
520 1 $a"Manual of Coagulation Disorders distills the most clinically relevant material from the more conventional reference books. Physicians and trainees who treat thrombotic and hemorrhagic disorders will discover new insight into human diseases caused by thrombosis and bleeding.".
520 8 $a"To provide comprehensive coverage, the author begins with a brief discussion of mechanisms of coagulation, venous and arterial thromboses, and associated syndromes. Readers are then taken through bleeding disorders, care of special patients, and specific complications resulting from relevant medical problems."--BOOK JACKET.
650 12 $aBlood Coagulation Disorders.$0https://id.nlm.nih.gov/mesh/D001778
650 22 $aAnticoagulants$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D000925Q000627
650 22 $aEmbolism.$0https://id.nlm.nih.gov/mesh/D004617
650 22 $aFibrinolytic Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D005343Q000627
650 22 $aPlatelet Aggregation Inhibitors$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D010975Q000627
650 22 $aThrombosis.$0https://id.nlm.nih.gov/mesh/D013927
700 1 $aKroll, Michael H.$0http://id.loc.gov/authorities/names/n2001126843
852 00 $boff,hsl$hRC647.C55$iK76 2001